Dr.Sunita Mohan [M11762] – Mumbai
Bedside to bench to bedside is how ophthalmology and vision sciences has to be practiced, so that it leads on to translational impact. Diabetic retinopathy (DR) is a blindness endemic affecting millions of people across the world and India would be one of the most affected in this medical episode. This IC would simplify the knowledge of complicated interactions between genetics to molecular biology and how its cellular manifestations eventuates into the disease pathology and clinical presentations. Knowledge on these eventualities would help us to identify the early biomarkers for not only clinical diagnosis but also early detection. Diagnosing the disease with cutting-edge imaging methods and developing robust artificial intelligence algorithms for early detection and prognostication. With all these information we shall see how DR presents itself as a universal manifesting disease and epidemiology.
| 1 | Global and Indian epidemiology update of diabetic retinopathy (10 mins) | Dr.Sunita Mohan | watch video |
| 2 | Understanding the molecular genetic mechanisms of DR disease pathology (10 mins | Prof.G Kumaramanickavel | watch video |
| 3 | Molecular biology of DR (10 mins) | Dr.S Rajkumar | watch video |
| 4 | Molecular and imaging biomarkers in DR (10 mins) | Dr.Sobha Sivaprasad | watch video |
| 5 | Next generation screening in DR: Artificial intelligence algorithms for diagnosis/prognostication (10 mins) | Dr.Rajiv Raman | watch video |
| 6 | Newer vistas in imaging of diabetic retinopathy (10 mins) | Dr.Kim Ramasamy | watch video |
| 7 | Keynote Address by Dr. MARTIN S ZINKERNGAEL : Gut Microbiome and Associationswith Retinal Diseases ( 10 min ) | Dr.Martin S Zinkerngael | watch video |
| Panel Discussion : (15 mins.) |


Leave a Comment